CROSSTALK BETWEEN AUTOPHAGY AND APOPTOSIS IN CD437-INDUCED А549 LUNG CARCINOMA CELL DEATH
https://doi.org/10.17650/1726-9784-2020-19-4-65-73
Abstract
Introduction. Synthetic retinoids CD437, an agonist of the gamma retinoic acid receptor (RARγ), not only induces growth arrest, but in contrast to retinoid acid, it also induces RARγ-independent apoptosis in many tumor cells through a unique mechanism that is independent of the retinoic acid receptor-mediated pathway.
The aim of the study was to study the relationship between apoptosis and autophagy in CD437-induced cell death.
Materials and methods. In this study we used 2D-culturing of lung carcinoma cells A549, immunocytochemistry, flow cytometry and fluorescence microscopy.
Results. CD437 at concentrations between 0.2 and 5.0 μM increased the number of PI-positive cells in A549 lung cancer cells. The retinoid at concentrations close to IC50 reduced the cell population in the G2/M-phase and arrest cell cycle in the S-phase. CD437 dose-dependent increased the number of apoptotic cells in the presence of non-cytotoxic concentrations of wortmanin, an irreversible inhibitor of anti-stress kinasе PI-3K, and LY 200192, a reversible inhibitor. CD437 also activated the biogenesis of autophagosomes, and there was a dose-dependent increase in the fluorescence intensity of monodansilkadaverine, a marker of autophagy. However, accumulation of LC-3B was not observed with an increase of CD437 concentration from 0.1 to 5.0 μM suggesting that the fusion between autophagic vacuoles and lysosomes was inhibited. zVAD-fmk, an irreversible caspase inhibitor, did not restore autophagy in A549 cells, and LC-3B levels did not change significantly with the increasing of CD437 concentration, indicating that CD437 was involved in autophagosome-lysosome fusion. When cells grew with non-cytotoxic concentrations of chlorokine, a late stage autophagy inhibitor, there were virtually no living cells at CD437 concentrations close to IC50. The additive effect of CD437 and chlorokine in inducing A549 cell death confirms that CD437 involved in fusion between autophagosomes and lysosomes required for final catabolism of autophagic material.
Conclusions. The data obtained indicate that CD437 induced a failure of cytoprotective function of autophagy and apoptosis, that raise the question of combined therapy of CD437 with cytotoxic drugs in the treatment of lung carcinomaAbout the Authors
A. A. VartanianRussian Federation
24 Kashirskoe Shosse, Moscow 115478
D. A. Khochenkov
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
E. N. Kosobokova
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
V. S. Kosorukov
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
References
1. Wolf G. A history of vitamin A and retinoids. FASEB J 1996;10:1102–1107. DOI: 10.1096/fasebj.10.9.8801174.
2. Goodman G.E., Alberts D.S., Meyskens F.L. Retinol, vitamins, and cancer prevention: 25 Years of learning and relearning. J Clin Oncol 2008;26:5495–6. DOI: 10.1200/JCO.2008.19.0884.
3. Smith W.E., Yazdi E., Miller L. Carcinogenesis in pulmonary epithelia in mice on different levels of vitamin A. Environ Res 1972;5:152–63. DOI: 10.1016/0013-9351(72)90030-8.
4. Zhao X., Spanjaard R.A. The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis. J Biomed Sci 2003;10(1):44–9. DOI: 10.1007/BF02255996.
5. Chen J.Y., Clifford J., Zusi C. Two distinct actions of retinoid-receptor ligands. Nature 1996;382(6594):819–22. DOI: 10.1038/382819a0.
6. Garattini E., Gianni M., Terao M. Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. Curr Pharm Des 2004;10(4):433–48. DOI: 10.2174/1381612043453351.
7. White E. The role for autophagy in cancer. J Clin Invest 2015;125(1):42–6. DOI: 10.1172/JCI73941.
8. Levy J.M., Towers C.G., Thorburn A. Targeting autophagy in cancer. Nature Reviews Cancer 2017;17(9):528–42. DOI: 10.1038/nrc.2017.53.
9. Bollag W., Isnardi L., Jablonska S. Links between pharmacological properties of retinoids and nuclear retinoid receptors. Int J Cancer 1997;70:470–2. PMID: 9033657.
10. Zhao X., Demary K., Wong L., Vaziri C. Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN). Cell Death Differ 2001;8(9):878–86. DOI: 10.1038/sj.cdd.4400894.
11. Shyu R.Y., Lin D.Y., Reichert U. Synthetic retinoid CD437 induces celldependent cycle arrest by differential regulation of cell cycle associated proteins. Anticancer Res 2002;22(5):2757–64. PMID: 12529993.
12. Lotan R. Receptor-independent induction of apoptosis by synthetic retinoids. J Biol Regul Homeost Agents 2003;17(1):13–28. PMID: 12757019.
13. Saxton R.A, Sabatini D.M. mTOR Signaling in Growth, Metabolism, and Disease. Сell 2017;168:960–76. PMID: 28283069.
14. Karimi Roshan M., Soltani A., Soleimani A. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie 2019;165:229–34. DOI: 10.1016/j.biochi.2019.08.003.
15. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009;19(1):71–88. DOI: 10.1038/cr.2008.302.
16. Xuefei Li, Xiaorong Hu, Jichun Wang. Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway. Int J Mol Med 2018;42(4):1917–24. DOI: 10.3892/ijmm.2018.3794.
17. Perry C.N., Kyoi S., Hariharan N. Novel methods for measuring cardiac autophagy. Methods Enzymol 2009;453:325–42. DOI: 10.1016/S0076-6879(08)04016-0.
18. Maheswari U., Sadras S.R. Mechanism and Regulation of Autophagy in Cancer. Crit Rev Oncog 2018;23(5v6):269–80. DOI: 10.1615/CritRevOncog.2018028394.
19. Wang Z., Liu G., Jiang J. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment. It J Oncol 2019;543:1071–85. DOI: 10.3892/ijo.2019.4690.
20. Wirawan E. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death & Disease 2010;1(1):e18. DOI: 10.1038/cddis.2009.16.
21. Pasquier B. Autophagy inhibitors. Cell Mol Life Sci 2016;73(5):985–1001. DOI: 10.1007/s00018-015-2104-y.
22. Merabishvily V.M., Arseniev A.I., Tarkov S.A. Lung cancer morbidity and mortality in population, accuracy of accounting. Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology 2018;17(6):15–26. (In Russ.).
23. Xu Z., Han X., Ou D., Liu T. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol 2020;104(2):575–87. DOI: 10.1007/s00253-019-10257-8.
24. Noonan J., Zarrer J., Murphy B.M. Targeting Autophagy in Glioblastoma. Crit Rev Oncog 2016;21(3–4):241–52. DOI: 10.1615/CritRevOncog.
25. Sun S.Y., Kurie J.M., Yue P. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids. Cancer Res 1999;5(2):431–7. PMID: 10037194.
26. Sun S.Y., Yue P., Chen X. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Cancer Res 2002;62(8):2430–6. PMID: 11956107.
Review
For citations:
Vartanian A.A., Khochenkov D.A., Kosobokova E.N., Kosorukov V.S. CROSSTALK BETWEEN AUTOPHAGY AND APOPTOSIS IN CD437-INDUCED А549 LUNG CARCINOMA CELL DEATH. Russian Journal of Biotherapy. 2020;19(4):65-73. (In Russ.) https://doi.org/10.17650/1726-9784-2020-19-4-65-73